FDA.reportPublic FDA data

mometasone / salicylic acid

RxCUI
1007669
RxNorm name
mometasone / salicylic acid
Term type
MIN
Status
Active
Updated
2026-10-17 23:54:06

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
mometasone108118
salicylic acid9525

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRmometasone / salicylic acid1NAMES
RxNorm Namemometasone / salicylic acid1NAMES
TTYMIN1ATTRIBUTES
RxCUI10076691CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01BCAntiinflammatory agents, non-steroidsATC1-4salicylic acid
ATCR01ADCorticosteroidsATC1-4mometasone
ATCD07ACCorticosteroids, potent (group III)ATC1-4mometasone
ATCD07XCCorticosteroids, potent, other combinationsATC1-4mometasone
ATCR03BAGlucocorticoidsATC1-4mometasone
ATCD01AEOther antifungals for topical useATC1-4salicylic acid
FDASPLN0000175576CorticosteroidEPChas_epcmometasone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moamometasone
MEDRTD000068656Mometasone FuroateCHEMhas_ingredientmometasone
MEDRTD020156Salicylic AcidCHEMhas_ingredientsalicylic acid
MEDRTD000152Acne VulgarisDISEASEmay_treatsalicylic acid
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD003881DermatomycosesDISEASEci_withmometasone
MEDRTD004342Drug HypersensitivityDISEASEci_withmometasone
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylic acid
MEDRTD005148Facial DermatosesDISEASEmay_treatmometasone
MEDRTD005533Foot DermatosesDISEASEmay_treatmometasone
MEDRTD006229Hand DermatosesDISEASEmay_treatmometasone
MEDRTD006561Herpes SimplexDISEASEci_withmometasone
MEDRTD006562Herpes ZosterDISEASEci_withmometasone
MEDRTD007249InflammationDISEASEmay_treatmometasone
MEDRTD017492Keratosis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD007868Leg DermatosesDISEASEmay_treatmometasone
MEDRTD011537PruritusDISEASEmay_treatmometasone
MEDRTD011565PsoriasisDISEASEmay_treatsalicylic acid
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatmometasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatmometasone
MEDRTD012536Scalp DermatosesDISEASEmay_treatsalicylic acid
MEDRTD014382Tuberculosis, CutaneousDISEASEci_withmometasone
MEDRTD014860WartsDISEASEmay_treatsalicylic acid
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamometasone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamometasone
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moasalicylic acid
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemometasone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemometasone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemometasone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemometasone
MEDRTN0000009974Increased Skin KeratinizationPEhas_pesalicylic acid
MEDRTN0000009908VasoconstrictionPEhas_pemometasone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI